Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PET/CT Reconstruction and Its Impact on [Measures of] Metabolic Tumor Volume.
Knaup H, Weindler J, van Heek L, Voltin CA, Fuchs M, Borchmann P, Dietlein M, Kobe C, Roth K. Knaup H, et al. Among authors: van heek l. Acad Radiol. 2024 Jul;31(7):3020-3025. doi: 10.1016/j.acra.2023.12.016. Epub 2023 Dec 27. Acad Radiol. 2024. PMID: 38155023 Free article.
Patterns of PET-positive residual tissue at interim restaging and risk of treatment failure in advanced-stage Hodgkin's lymphoma: an analysis of the randomized phase III HD18 trial by the German Hodgkin Study Group.
Ferdinandus J, van Heek L, Roth K, Dietlein M, Eich HT, Baues C, Borchmann P, Kobe C. Ferdinandus J, et al. Among authors: van heek l. Eur J Nucl Med Mol Imaging. 2024 Jan;51(2):490-495. doi: 10.1007/s00259-023-06431-w. Epub 2023 Sep 22. Eur J Nucl Med Mol Imaging. 2024. PMID: 37735258 Free PMC article. Clinical Trial.
Prognostic value of baseline metabolic tumor volume (MTV) for forecasting chemotherapy outcome in early-stage unfavorable Hodgkin lymphoma: Data from the phase III HD17 trial.
van Heek L, Weindler J, Gorniak C, Kaul H, Müller H, Mettler J, Baues C, Fuchs M, Borchmann P, Ferdinandus J, Dietlein M, Voltin CA, Kobe C, Roth KS. van Heek L, et al. Eur J Haematol. 2023 Dec;111(6):881-887. doi: 10.1111/ejh.14093. Epub 2023 Aug 29. Eur J Haematol. 2023. PMID: 37644732
Dual-tracer PET/CT protocol with [18F]FDG and [68Ga]Ga-FAPI-46 outperforms single-tracer PET/CT with [18F]FDG in different cancer types, resulting in larger functional and gross tumor volume.
Wegen S, Weindler J, Voltin CA, van Heek L, Schomäcker K, Fischer T, Marnitz S, Kobe C, Drzezga A, Roth KS. Wegen S, et al. Among authors: van heek l. Strahlenther Onkol. 2024 Jan;200(1):28-38. doi: 10.1007/s00066-023-02117-2. Epub 2023 Aug 16. Strahlenther Onkol. 2024. PMID: 37584717 Free PMC article.
First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer.
Wegen S, Roth KS, Weindler J, Claus K, Linde P, Trommer M, Akuamoa-Boateng D, van Heek L, Baues C, Schömig-Markiefka B, Schomäcker K, Fischer T, Drzezga A, Kobe C, Köhler C, Marnitz S. Wegen S, et al. Among authors: van heek l. Clin Nucl Med. 2023 Feb 1;48(2):150-155. doi: 10.1097/RLU.0000000000004505. Clin Nucl Med. 2023. PMID: 36607364 Free PMC article.
Head-to-Head Comparison of [68 Ga]Ga-FAPI-46-PET/CT and [18F]F-FDG-PET/CT for Radiotherapy Planning in Head and Neck Cancer.
Wegen S, van Heek L, Linde P, Claus K, Akuamoa-Boateng D, Baues C, Sharma SJ, Schomäcker K, Fischer T, Roth KS, Klußmann JP, Marnitz S, Drzezga A, Kobe C. Wegen S, et al. Among authors: van heek l. Mol Imaging Biol. 2022 Dec;24(6):986-994. doi: 10.1007/s11307-022-01749-7. Epub 2022 Jun 30. Mol Imaging Biol. 2022. PMID: 35771317 Free PMC article. Clinical Trial.
Influences on PET Quantification and Interpretation.
Rogasch JMM, Hofheinz F, van Heek L, Voltin CA, Boellaard R, Kobe C. Rogasch JMM, et al. Among authors: van heek l. Diagnostics (Basel). 2022 Feb 10;12(2):451. doi: 10.3390/diagnostics12020451. Diagnostics (Basel). 2022. PMID: 35204542 Free PMC article. Review.
14 results